Response to Esketamine Therapy for Treatment-Resistant Depression
Steven Levine, MD: All 3 of you have experience prescribing intranasal esketamine in a carefully screened population for an appropriate patient under careful medical conditions, so this question is for any of you. What is typical? How quickly do you tend to see improvements in depressive symptoms for these patients when they do respond? Lisa […]
Response to Esketamine Therapy for Treatment-Resistant Depression Read More »